Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction

Citation

Belarte-Tornero LC, Mojón D, Solé-González E, Ruiz-Bustillo S, Valdivielso-More S, Farré N. Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1117-9. DOI: 10.1016/j.rec.2021.06.005

Abstract

Other authors

Description

Collection

Alternative title

Referenced by

Related Publication/Data

Citations

Dimensions
PlumX
Altmetrics
Scopus Logo0
Crossref Cited-by logo   0
Datacite Logo
Scimago Logo
Google Scholar Logo

Share